NO900483L - Fremgangsmaate for fremstilling av et nedbrytbart gemfibrozil-preparat. - Google Patents

Fremgangsmaate for fremstilling av et nedbrytbart gemfibrozil-preparat.

Info

Publication number
NO900483L
NO900483L NO90900483A NO900483A NO900483L NO 900483 L NO900483 L NO 900483L NO 90900483 A NO90900483 A NO 90900483A NO 900483 A NO900483 A NO 900483A NO 900483 L NO900483 L NO 900483L
Authority
NO
Norway
Prior art keywords
preparation
gemfibrozil
degradable
procedure
granulation
Prior art date
Application number
NO90900483A
Other languages
English (en)
Norwegian (no)
Other versions
NO900483D0 (no
Inventor
Isaac Ghebre-Sellassie
Mahdi B Fawzi
Uma Iyer
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO900483D0 publication Critical patent/NO900483D0/no
Publication of NO900483L publication Critical patent/NO900483L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO90900483A 1989-02-02 1990-02-01 Fremgangsmaate for fremstilling av et nedbrytbart gemfibrozil-preparat. NO900483L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/305,083 US4925676A (en) 1989-02-02 1989-02-02 Extended release gemfibrozil composition

Publications (2)

Publication Number Publication Date
NO900483D0 NO900483D0 (no) 1990-02-01
NO900483L true NO900483L (no) 1990-08-03

Family

ID=23179257

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90900483A NO900483L (no) 1989-02-02 1990-02-01 Fremgangsmaate for fremstilling av et nedbrytbart gemfibrozil-preparat.

Country Status (20)

Country Link
US (1) US4925676A (fr)
EP (1) EP0381218B1 (fr)
JP (1) JPH02235810A (fr)
CN (1) CN1044590A (fr)
AT (1) ATE88888T1 (fr)
AU (1) AU624217B2 (fr)
CA (1) CA2009134A1 (fr)
DE (1) DE69001487T2 (fr)
DK (1) DK0381218T3 (fr)
ES (1) ES2055176T3 (fr)
FI (1) FI900492A7 (fr)
HU (1) HU204194B (fr)
IE (1) IE900372L (fr)
IL (1) IL92995A0 (fr)
MY (1) MY104899A (fr)
NO (1) NO900483L (fr)
NZ (1) NZ232322A (fr)
PH (1) PH26308A (fr)
PT (1) PT93028A (fr)
ZA (1) ZA90778B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1246382B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
EP0462067A1 (fr) * 1990-06-15 1991-12-18 Warner-Lambert Company Formulations de gemfibrozil
EP0462066A1 (fr) * 1990-06-15 1991-12-18 Warner-Lambert Company Gemfibrozil amorphe
EP0475894A1 (fr) * 1990-08-27 1992-03-18 Warner-Lambert Company Formulations améliorées de gemfibozile
US5102668A (en) * 1990-10-05 1992-04-07 Kingaform Technology, Inc. Sustained release pharmaceutical preparation using diffusion barriers whose permeabilities change in response to changing pH
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
MY110880A (en) * 1991-01-30 1999-06-30 The Wellcome Foundation Ltd Water-dispersible tablets
US5492700A (en) * 1991-11-26 1996-02-20 Warner-Lambert Company Process and composition for the development of controlled release gemfibrozil dosage form
US5358723A (en) * 1991-11-26 1994-10-25 Warner-Lambert Company Process and composition for the development of controlled release gemfibrozil dosage form
JPH07503236A (ja) * 1991-11-26 1995-04-06 ワーナー−ランバート・コンパニー 制御放出性ジェムフィブロジル剤形の開発のための方法および組成物
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
HU212428B (en) * 1994-05-13 1996-06-28 Egyt Gyogyszervegyeszeti Gyar Process to prepare pharmaceutical compositions containing gemfibrozyl
US6838091B2 (en) * 1998-12-18 2005-01-04 Abbott Laboratories Formulations comprising lipid-regulating agents
US7014864B1 (en) 1998-12-18 2006-03-21 Abbott Laboratories Formulations comprising lipid-regulating agents
US6814977B1 (en) 1998-12-18 2004-11-09 Abbott Laboratories Formulations comprising lipid-regulating agents
US6719999B2 (en) 1999-03-31 2004-04-13 Abbott Laboratories Formulations comprising lipid-regulating agents
US6372251B2 (en) 1999-06-11 2002-04-16 Abbott Laboratories Formulations comprising lipid-regulating agents
CN101480384A (zh) * 2002-12-17 2009-07-15 阿伯特有限及两合公司 包含非诺贝酸、其生理可接受的盐或衍生物的制剂
WO2005123045A2 (fr) * 2004-06-10 2005-12-29 Glatt Air Techniques, Inc. Formulation a dosage pharmaceutique contenant une matrice a liberation controlee

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132753A (en) * 1965-02-12 1979-01-02 American Cyanamid Company Process for preparing oral sustained release granules
US4291016A (en) * 1976-07-27 1981-09-22 Sandoz Ltd. Enteric coated mixture of 4-(2-hydroxy-3-isopropylamino-propoxy) indole and sodium lauryl sulphate
US4195084A (en) * 1977-01-07 1980-03-25 Eli Lilly And Company Taste-stable aqueous pharmaceutical suspension of tall oil sitosterols and a method for the preparation thereof
IT1101649B (it) * 1978-12-15 1985-10-07 Lehner Ag Composizione farmaceutica ad azione prolungata contenente acidi biliari
JPS57171428A (en) * 1981-04-13 1982-10-22 Sankyo Co Ltd Preparation of coated solid preparation
JPS59193831A (ja) * 1983-04-18 1984-11-02 Sankyo Co Ltd 腸溶性製剤の製造法
HU190619B (en) * 1983-11-11 1986-09-29 Bezzegh,Denes,Hu Process for producing tablets with controlled dissolution of active ingredients
DE3678644D1 (de) * 1985-08-16 1991-05-16 Procter & Gamble Wirkstoffpartikel mit sowohl kontinuierlicher als auch schneller freisetzung.
US4778676A (en) * 1985-12-20 1988-10-18 Warner-Lambert Company Confectionery delivery system for actives
IL81419A0 (en) * 1986-01-30 1987-08-31 Syntex Inc Long acting sustained release pharmaceutical compositions containing dihydropyridines and their preparation
US4716033A (en) * 1986-03-27 1987-12-29 Warner-Lambert Company Medicament adsorbates with surfactant and their preparation
US4816264A (en) * 1986-06-06 1989-03-28 Warner-Lambert Company Sustained release formulations
US4814354A (en) * 1986-09-26 1989-03-21 Warner-Lambert Company Lipid regulating agents
WO1988005296A2 (fr) * 1987-01-27 1988-07-28 Warner-Lambert Company Compositions regulatrices de lipides

Also Published As

Publication number Publication date
NZ232322A (en) 1991-02-26
EP0381218A3 (en) 1990-12-05
EP0381218B1 (fr) 1993-05-05
HU900640D0 (en) 1990-04-28
PT93028A (pt) 1990-08-31
CA2009134A1 (fr) 1990-08-02
US4925676A (en) 1990-05-15
DK0381218T3 (da) 1993-06-01
CN1044590A (zh) 1990-08-15
JPH02235810A (ja) 1990-09-18
IL92995A0 (en) 1990-09-17
ES2055176T3 (es) 1994-08-16
DE69001487T2 (de) 1993-08-26
DE69001487D1 (de) 1993-06-09
PH26308A (en) 1992-04-29
HU204194B (en) 1991-12-30
MY104899A (en) 1994-06-30
ZA90778B (en) 1991-10-30
ATE88888T1 (de) 1993-05-15
AU4899090A (en) 1990-08-09
AU624217B2 (en) 1992-06-04
IE900372L (en) 1990-08-02
FI900492A7 (fi) 1990-08-03
HUT52952A (en) 1990-09-28
FI900492A0 (fi) 1990-01-31
NO900483D0 (no) 1990-02-01
EP0381218A2 (fr) 1990-08-08

Similar Documents

Publication Publication Date Title
NO900483L (no) Fremgangsmaate for fremstilling av et nedbrytbart gemfibrozil-preparat.
NO892826D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat for aa forhindre seksuelt overfoerbare sykdommer.
MA22245A1 (fr) Procede de preparation de compositions a liberation prolongee et compositions ainsi obtenues
NO900338D0 (no) Fremgangsmaate for befestigelse av en slange til en nippelog en derved tilveiebragt forbindelse.
NO891906D0 (no) Fremgangsmaate for fremstilling av et harpiksadsorbat av ranitidin.
NO901372L (no) Framgangsmaate for tilvirking av medikament-baerer.
FR2685869B1 (fr) Compositions therapeutiques a base d'inhibiteurs mixtes de la no synthase et de la cyclooxygenase.
ES2055177T3 (es) Composicion de gemfibrozil con liberacion modificada.
NO306619B1 (no) Farmasöytisk preparat inneholdende en hemmer av testosteron 5<alfa>-reduktaseaktivitet samt anvendelse av slik hemmer for fremstilling av et legemiddel
NO883500L (no) Fremgangsmaate for fremstilling av et farmasoeytisk aktivt nitrometan.
NO904513D0 (no) Fremgangsmaate for fremstilling av et naeringsmiddel.
NO901702L (no) Anordning for aa hindre tilbakespretting av en masse som treffer et maalelement.
NO171792C (no) Fremgangsmaate for fremstilling av en friradikal-addisjonspolymer
AU4480889A (en) A pharmaceutical composition for rapid release of the active component comprising an orderred mixture and a surfactant
IL59764A (en) Programmed release pharmaceutical composition based on dihydroergotoxine and procedure for its manufacture
NO921603D0 (no) Fremgangsmaate til fremstilling av et aktivt findelt agregat for bruk til betong
ES494878A0 (es) Un procedimiento para la preparacion de (a)-esteres de acidohexahidrobenzoico y otros acidos carboxilicos alifaticos o cicloalifaticos
FR2621368B1 (fr) Joint homocinetique du type tripode a retenue axiale
DK62588D0 (da) Fremgangsmaade til fremstilling af faste polyhalogentriaryl-phosphatestere
NO885682L (no) Fremgangsmaate for fremstilling av farmasoeytiske produktermed langvarig frigivende virkning.
NO903838D0 (no) Fremgangsmaate for fremstilling av tamponger samt tampong fremstilt derved.
ES531229A0 (es) Un procedimiento de preparacion de esteres tiofosforicos y tiofosfonicos heterociclicos
BE877242A (fr) Esters d'acides steroidaux (16 alpha, 17-beta)naphtaleno- et cyclohexene-21-carboxyliques, a proprietes anti-inflammatoires
KR900011111U (ko) 모니터의 초기 영상 뮤트 회로
NO890539D0 (no) Fremgangsmaate for fremstilling av lipofile oxadiazoler.